ealth Care Biotechnology RTRX.OQ Bloomberg RTRX US Exchange Ticker NMS RTRX Company Retrophin Agrees to sell PRV for $245M, new TP of $52 Retrophin agrees to sell its PRV to SNY for $245M, new TP of $52 This morning RTRX announced that it plans to sell the rare pediatric priority review voucher